NO20014411L - Lipoglykan-blandinger og metoder for behandling av parasitt- infeksjoner - Google Patents

Lipoglykan-blandinger og metoder for behandling av parasitt- infeksjoner

Info

Publication number
NO20014411L
NO20014411L NO20014411A NO20014411A NO20014411L NO 20014411 L NO20014411 L NO 20014411L NO 20014411 A NO20014411 A NO 20014411A NO 20014411 A NO20014411 A NO 20014411A NO 20014411 L NO20014411 L NO 20014411L
Authority
NO
Norway
Prior art keywords
lipoglycan
compositions
treatment
methods
parasite infections
Prior art date
Application number
NO20014411A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014411D0 (no
Inventor
Lloyd H Semprevivo
Original Assignee
Univ Massachusetts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Massachusetts filed Critical Univ Massachusetts
Publication of NO20014411D0 publication Critical patent/NO20014411D0/no
Publication of NO20014411L publication Critical patent/NO20014411L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Materials Engineering (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
NO20014411A 1999-03-12 2001-09-11 Lipoglykan-blandinger og metoder for behandling av parasitt- infeksjoner NO20014411L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12393199P 1999-03-12 1999-03-12
PCT/US2000/006404 WO2000053220A1 (en) 1999-03-12 2000-03-10 Lipoglycan compositions and methods of treating parasitic infections

Publications (2)

Publication Number Publication Date
NO20014411D0 NO20014411D0 (no) 2001-09-11
NO20014411L true NO20014411L (no) 2001-11-09

Family

ID=22411778

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014411A NO20014411L (no) 1999-03-12 2001-09-11 Lipoglykan-blandinger og metoder for behandling av parasitt- infeksjoner

Country Status (17)

Country Link
US (3) US6428793B1 (tr)
EP (1) EP1175226B1 (tr)
JP (1) JP2002538220A (tr)
AT (1) ATE439857T1 (tr)
AU (1) AU771373B2 (tr)
BR (1) BR0008949A (tr)
CA (1) CA2364507A1 (tr)
DE (1) DE60042776D1 (tr)
HU (1) HUP0200466A3 (tr)
MA (1) MA25347A1 (tr)
MX (1) MXPA01009206A (tr)
NO (1) NO20014411L (tr)
NZ (1) NZ514112A (tr)
PL (1) PL203789B1 (tr)
TR (3) TR200202078T2 (tr)
WO (1) WO2000053220A1 (tr)
ZA (1) ZA200107502B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
US7164520B2 (en) 2004-05-12 2007-01-16 Idc, Llc Packaging for an interferometric modulator
WO2006041613A2 (en) * 2004-10-05 2006-04-20 Nanomega Medical Corporation Nanoparticles for targeting hepatoma cells
CA2777883A1 (en) * 2009-10-21 2011-04-28 Eth Zurich Medical utility of glycan-binding proteins and glycans

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598147B1 (fr) * 1986-04-30 1988-08-26 Pasteur Institut Immunogene isole de mollusques, son procede de preparation, reactifs de diagnostic des bilharzioses humaines, vaccins contre les schistosomiases et compositions immunisantes comprenant ledit immunogene.
FR2601021B2 (fr) * 1986-07-07 1988-11-18 Pasteur Institut Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant
US5280113A (en) 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5212298A (en) * 1989-08-16 1993-05-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5679347A (en) 1992-12-10 1997-10-21 Brigham And Women's Hospital Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
US5541075A (en) * 1993-02-05 1996-07-30 Heska Corporation Carbohydrate-based vaccine and diagnostic reagent for trichinosis
BR9305075A (pt) * 1993-12-16 1995-08-08 Fundacao Oswaldo Cruz Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico
AU5928999A (en) * 1998-09-21 2000-04-10 Richard D. Cummings Assays for helminth infections

Also Published As

Publication number Publication date
PL203789B1 (pl) 2009-11-30
ZA200107502B (en) 2003-02-26
US6428793B1 (en) 2002-08-06
DE60042776D1 (de) 2009-10-01
TR200202066T2 (tr) 2004-12-21
EP1175226A1 (en) 2002-01-30
NZ514112A (en) 2003-08-29
AU3625100A (en) 2000-09-28
MXPA01009206A (es) 2003-07-14
US20060228382A1 (en) 2006-10-12
PL350989A1 (en) 2003-02-24
HUP0200466A3 (en) 2006-11-28
US7204983B2 (en) 2007-04-17
HUP0200466A2 (en) 2002-06-29
WO2000053220A1 (en) 2000-09-14
BR0008949A (pt) 2002-09-24
US20020160021A1 (en) 2002-10-31
NO20014411D0 (no) 2001-09-11
US7063848B2 (en) 2006-06-20
TR200103231T2 (tr) 2002-03-21
CA2364507A1 (en) 2000-09-14
JP2002538220A (ja) 2002-11-12
EP1175226B1 (en) 2009-08-19
EP1175226A4 (en) 2005-01-05
ATE439857T1 (de) 2009-09-15
AU771373B2 (en) 2004-03-18
MA25347A1 (fr) 2001-12-31
TR200202078T2 (tr) 2002-11-21

Similar Documents

Publication Publication Date Title
AU2147992A (en) Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
SE9704870D0 (sv) New pharmaceutical formulation I
ATE192153T1 (de) Amino-imidazo (4,5-c) chinoline
DE69425671T2 (de) Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
DE69325370D1 (de) Attenuierter respiratorischer synzytialvirus enthaltende impfstoff-zusammensetzungen
AU4660893A (en) Deletion mutants as vaccines for cholera
PT99513A (pt) Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
PT692028E (pt) Farmacos baseados em papilomavirus
DK1501499T3 (da) Transepikutan indgivelsesform til behandling af restless legs-syndromet
DK83794A (da) Farmaceutiske præparater indeholdende nifedipin og fremgangsmåde til fremstilling heraf
ATE249824T1 (de) Verfahren zur behandlung von hypersensitivität typ i unter verwendung von monophosphoryl-lipid a
NO20014411L (no) Lipoglykan-blandinger og metoder for behandling av parasitt- infeksjoner
WO2000057908A3 (en) Attenuated dengue-1 virus vaccine
CA2063721A1 (fr) Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae
NO913131L (no) Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid.
WO1991000081A3 (en) Anti-malarial composition and method of use
AU6942896A (en) Use of muteins of wild-type cytokines as immunogens
DE60045516D1 (de) Pflanzen lektine als mukosale adjuvantien
WO2003006645A3 (en) Method and composition for inhibiting heparanase activity
SUZUKI et al. Feeding assemblage of the Oriental Greenfinch Carduelis sinica observed on Hahajima, the Ogasawara Islands
WO2000051635A3 (en) Emulsan and emulsan analogs immunization formulations and use
NO980127L (no) Anvendelse av ipriflavon for å redusere antall CD8+ celler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application